Funding Rounds
Avextra

Avextra Series B (2024, $21M)

Avextra

Cannabis-based medicines developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $21.54M

Raised Date: 2024-07-01